Skip to content

Stem Cell Related Donor Safety Study

A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00948636
Acronym
RDSafe
Enrollment
1812
Registered
2009-07-29
Start date
2010-01-31
Completion date
2016-09-30
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Related Hematopoietic Stem Cell Donors

Brief summary

The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors. The study will also assess the hypothesis that young (\<18 years) and older (\>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations. An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Utah
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
Center for International Blood and Marrow Transplant Research
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Donors of any age providing either a first or second BM or PBSC donation * Meet donation criteria per institution policies and procedures * Willing to receive phone follow-up at 1, 6, and 12 months * Signed informed consent for study participation For the HRQoL ancillary study, inclusion criteria: * Related donors age greater than or equal to 5, eligible and consented to the primary trial by the above listed inclusion criteria * Donors competent to answer psychological assessment questions by themselves, or if a child, should be able to respond to psychological assessment questions and have an appropriate proxy also able to complete the HRQoL proxy interview * English speaking * Access to a telephone * Willing to participate in pre-donation, 1 month and 1 year follow-up interviews * Signed informed consent for study participation in ancillary study

Exclusion criteria

* Per institutional guidelines * Donors providing unstimulated peripheral blood stem cells or lymphocytes For the HRQoL ancillary study,

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026